L
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K443.0 KBLUMOS PHARMA, INC.Dec 12, 10:28 AM ET·0001193125-24-276512
- 8-K289.0 KBLUMOS PHARMA, INC.Nov 25, 6:02 AM ET·0001140361-24-047709
- SC 13G27.8 KBLUMOS PHARMA, INC.Nov 12, 6:27 PM ET·0001085146-24-005565
- 10-Q5.0 MBLUMOS PHARMA, INC.Nov 7, 3:12 PM ET·0001126234-24-000097
- 8-K1.3 MBLUMOS PHARMA, INC.Oct 23, 8:10 AM ET·0001140361-24-043979
- 10-Q4.3 MBLUMOS PHARMA, INC.Aug 2, 8:18 AM ET·0001126234-24-000088
- 8-K1.8 MBLUMOS PHARMA, INC.Aug 1, 5:07 PM ET·0001126234-24-000086
- 8-K7.8 MBLUMOS PHARMA, INC.Jun 5, 4:09 PM ET·0001126234-24-000066
- 10-Q4.0 MBLUMOS PHARMA, INC.May 15, 4:05 PM ET·0001126234-24-000062
- 8-K2.6 MBLUMOS PHARMA, INC.May 15, 9:57 AM ET·0001126234-24-000059
Insiders
10- Cunningham EmmettDirector
- DEERFIELD MANAGEMENT COMPANY, L.P.10% Owner, Possible Member of 10% Group
- Deerfield Private Design Fund III, L.P.10% Owner, Possible Member of 10% Group
- Edick Paul RDirector
- Flynn James E10% Owner, Possible Member of 10% Group
- Hawkins Richard JDirector, Chief Executive Officer
- HENNEMAN JOHN B IIIEVP, Chief Financial Officer
- JOHNSON CHAD ALLENDirector
- Karpf David BChief Medical Officer
- Kennedy Eugene P.Chief Medical Officer
Tickers
No tickers on record
Addresses
business
4200 MARATHON BLVD. SUITE 200
AUSTIN, TX, 78756
mailing
4200 MARATHON BLVD. SUITE 200
AUSTIN, TX, 78756
Former Names
- NEWLINK GENETICS CORP2020-03-20